본문 바로가기
KERD
논문KCI 등재

Analysis of Cholangitis Rates with Extended Perioperative Antibiotics and Adjuvant Corticosteroids in Biliary Atresia

1

조회

0

다운로드

0

인용

0

참고문헌

키워드

주제분류소아과학

초록

Purpose: There is no consensus regarding adjuvant therapies following Kasai portoenterostomy (KP) for biliary atresia (BA). This study aimed to analyze the effect of extended perioperative intravenous antibiotics (PI-Abx) and adjuvant corticosteroid on cholangitis and jaundice clearance rates in the 3 years post-KP in children with BA. Methods: Data of patients who underwent KP between 1999-2018 at a single center were retrospectively analyzed. Group A (1999–2010) received PI-Abx for 5 days, Group B (2010–2012) received PI-Abx for 5 days plus low-dose prednisolone (2 mg/kg), and Group C (2012–2017) received PI-Abx for 14 days plus high-dose prednisolone (5 mg/kg). Results: Fifty-four patients were included with groups A, B, and C comprising 25, 9, and 20 patients, respectively. The number of episodes of cholangitis was 1.0, 1.6, and 1.3 per patient (p=NS) within the first year and 1.8, 2.3, and 1.7 (p=NS) over 3 years in Groups A, B, and C, respectively. The jaundice clearance rate at 6 months was 52%, 78%, and 50% (p=NS), and the 3-year native liver survival (NLS) rate was 76%, 100%, and 80% (p=NS) in Groups A, B, and C, respectively. A near-significant association was observed between the incidence of cholangitis within the first year and decompensated liver cirrhosis/death at 3 years post KP (p=0.09). Persistence of jaundice at 6 months was significantly associated with decompensated cirrhosis/death at 3 years (p<0.001). Conclusion: The extended duration of PI-Abx and adjuvant corticosteroids was not associated with improved rates of cholangitis, jaundice clearance, or NLS in patients with BA.

Abstract

Purpose: There is no consensus regarding adjuvant therapies following Kasai portoenterostomy (KP) for biliary atresia (BA). This study aimed to analyze the effect of extended perioperative intravenous antibiotics (PI-Abx) and adjuvant corticosteroid on cholangitis and jaundice clearance rates in the 3 years post-KP in children with BA. Methods: Data of patients who underwent KP between 1999-2018 at a single center were retrospectively analyzed. Group A (1999–2010) received PI-Abx for 5 days, Group B (2010–2012) received PI-Abx for 5 days plus low-dose prednisolone (2 mg/kg), and Group C (2012–2017) received PI-Abx for 14 days plus high-dose prednisolone (5 mg/kg). Results: Fifty-four patients were included with groups A, B, and C comprising 25, 9, and 20 patients, respectively. The number of episodes of cholangitis was 1.0, 1.6, and 1.3 per patient (p=NS) within the first year and 1.8, 2.3, and 1.7 (p=NS) over 3 years in Groups A, B, and C, respectively. The jaundice clearance rate at 6 months was 52%, 78%, and 50% (p=NS), and the 3-year native liver survival (NLS) rate was 76%, 100%, and 80% (p=NS) in Groups A, B, and C, respectively. A near-significant association was observed between the incidence of cholangitis within the first year and decompensated liver cirrhosis/death at 3 years post KP (p=0.09). Persistence of jaundice at 6 months was significantly associated with decompensated cirrhosis/death at 3 years (p<0.001). Conclusion: The extended duration of PI-Abx and adjuvant corticosteroids was not associated with improved rates of cholangitis, jaundice clearance, or NLS in patients with BA.

참고문헌 (39)

  1. Altman RP, "A multivariable risk factor analysis of the portoenterostomy(Kasai)procedure for biliary atresia : twenty-five years of experience from two centers", Ann Surg, 226, pp.348~353 (1997)
  2. Davenport M, "Biliary atresia : the King's College Hospital experience(1974-1995)", J Pediatr Surg, 32, pp.479~485 (1997)
  3. Ryckman FC, "Biliary atresia--surgical management and treatment options as they relate to outcome", Liver Transpl Surg, 4(5 Suppl 1), pp.S24~S33 (1998)
  4. Koga H, "Factors influencing jaundice-free survival with the native liver in post-portoenterostomy biliary atresia patients : results from a single institution", J Pediatr Surg, 48, pp.2368~2372 (2013)
  5. Decharun K, "Prophylactic antibiotics for prevention of cholangitis in patients with biliary atresia status post-Kasai portoenterostomy : a systematic review", Clin Pediatr(Phila), 55, pp.66~72 (2016)
  6. Meyers RL, "High-dose steroids, ursodeoxycholic acid, and chronic intravenous antibiotics improve bile flow after Kasai procedure in infants with biliary atresia", J Pediatr Surg, 38, pp.406~411 (2003)
  7. Stringer MD, "Kasai portoenterostomy : 12-year experience with a novel adjuvant therapy regimen", J Pediatr Surg, 42, pp.1324~1328 (2007)
  8. Petersen C, "Postoperative high-dose steroids do not improve mid-term survival with native liver in biliary atresia", Am J Gastroenterol, 103, pp.712~719 (2008)
  9. Suzuki T, "Evaluating patients' outcome post-Kasai operation : a 19-year experience with modification of the hepatic portoenterostomy and applying a novel steroid therapy regimen", Pediatr Surg Int, 26, pp.825~830 (2010)
  10. Tyraskis A, "Glucocorticosteroids for infants with biliary atresia following Kasai portoenterostomy", Cochrane Database Syst Rev, 5, pp.CD008735~ (2018)
  11. Davenport M, "Randomized, double-blind, placebo-controlled trial of corticosteroids after Kasai portoenterostomy for biliary atresia", Hepatology, 46, pp.1821~1827 (2007)
  12. Kiriyama S, "Tokyo Guidelines 2018 : diagnostic criteria and severity grading of acute cholangitis(with videos)", J Hepatobiliary Pancreat Sci, 25, pp.17~30 (2018)
  13. Forum on Emerging Infections, Institute of Medicine, "2nd Workshop of the Forum on Emerging Infections; 1997 Jul 30-31" (1998), National Academy Press
  14. McDiarmid SV, "Selection of pediatric candidates under the PELD system", Liver Transpl, 10(10 Suppl 2), pp.S23~S30 (2004)
  15. European Association for the Study of the Liver, "EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis", J Hepatol, 69, pp.406~460 (2018)
  16. Luo Y, "Current concept about postoperative cholangitis in biliary atresia", World J Pediatr, 4, pp.14~19 (2008)
  17. Chen SY, "Number of cholangitis episodes as a prognostic marker to predict timing of liver transplantation in biliary atresia patients after Kasai portoenterostomy", BMC Pediatr, 18, pp.119~ (2018)
  18. Liu J, "Risk factors and prognostic effects of cholangitis after Kasai procedure in biliary atresia patients : a retrospective clinical study", J Pediatr Surg, 54, pp.2559~2564 (2019)
  19. Hung PY, "Long-term prognosis of patients with biliary atresia : a 25 year summary", J Pediatr Gastroenterol Nutr, 42, pp.190~195 (2006)
  20. Chung PH, "Predictors for failure after Kasai operation", J Pediatr Surg, 50, pp.293~296 (2015)
  21. Lünzmann K, "The influence of cholangitis on the prognosis of extrahepatic biliary atresia", Eur J Pediatr Surg, 9, pp.19~23 (1999)
  22. Lee JY, "Cholangitis in children with biliary atresia : health-care resource utilisation", J Paediatr Child Health, 50, pp.196~201 (2014)
  23. Wang Z, "Five-year native liver survival analysis in biliary atresia from a single large Chinese center : the death", liver transplantation hazard change and the importance of rapid early clearance of jaundice, 2019, pp.54, 1680~1685
  24. Tamgal J, "Clearance of jaundice after the modified Kasai's operation predicts survival outcomes in patients with biliary atresia", Turk J Pediatr, 61, pp.7~12 (2019)
  25. Pakarinen MP, "Outcomes of biliary atresia in the Nordic countries-a multicenter study of 158 patients during 2005-2016", J Pediatr Surg, 53, pp.1509~1515 (2018)
  26. Davenport M, "Biliary atresia in England and Wales : results of centralization and new benchmark", J Pediatr Surg, 46, pp.1689~1694 (2011)
  27. Ernest van Heurn LW, "Cholangitis after hepatic portoenterostomy for biliary atresia : a multivariate analysis of risk factors", J Pediatr, 142, pp.566~571 (2003)
  28. Wu ET, "Bacterial cholangitis in patients with biliary atresia : impact on short-term outcome", Pediatr Surg Int, 17, pp.390~395 (2001)
  29. Baek SH, "The epidemiology and etiology of cholangitis after Kasai portoenterostomy in patients with biliary atresia", J Pediatr Gastroenterol Nutr, 70, pp.171~177 (2020)
  30. Bezerra JA, "Use of corticosteroids after hepatoportoenterostomy for bile drainage in infants with biliary atresia : the START randomized clinical trial", JAMA, 311, pp.1750~1759 (2014)
  31. Cheng K, "Cholangitis in patients with biliary atresia receiving hepatoportoenterostomy : a national database study", J Pediatr Gastroenterol Nutr, 71, pp.452~458 (2020)
  32. Chen Y, "Postoperative steroid therapy for biliary atresia : systematic review and meta-analysis", J Pediatr Surg, 50, pp.1590~1594 (2015)
  33. Dillon PW, "Immunosuppression as adjuvant therapy for biliary atresia", J Pediatr Surg, 36, pp.80~85 (2001)
  34. Muraji T, "The improved outlook for biliary atresia with corticosteroid therapy", J Pediatr Surg, 32, pp.1103~1106 (1997)
  35. Alonso EM, "Impact of steroid therapy on early growth in infants with biliary atresia : the multicenter steroids in biliary atresia randomized trial", J Pediatr, 202, pp.179~185 (2018)
  36. McKiernan PJ, "The frequency and outcome of biliary atresia in the UK and Ireland", Lancet, 355, pp.25~29 (2000)
  37. Pietrobattista A, "Does the treatment after Kasai procedure influence biliary atresia outcome and native liver survival?", J Pediatr Gastroenterol Nutr, 71, pp.446~451 (2020)
  38. Wong ZH, "What happens after Kasai for biliary atresia? A European multicenter survey", Eur J Pediatr Surg, 29, pp.1~6 (2019)
  39. Mack CL, "A phase I", IIa trial of intravenous immunoglobulin following portoenterostomy in biliary atresia, 2019, pp.68, 495~501

관련 논문AI추천

Combined Predictors of Long-Term Outcomes of Kasai Surgery in Infants with Biliary AtresiaAlexander Razumovsky, Anna Degtyareva, Anna Sugak, Denis Rebrikov, Elena Filippova, Elena Tumanova, Marina Albegova, Medan Isaeva, Nadezhda Kulikova대한소아소화기영양학회 · Pediatric Gastroenterology, Hepatology & Nutrition2024 · 제27권 제4호Peri-Operative Liver Fibrosis and Native Liver Survival in Pediatric Patients with Biliary Atresia: A Systematic Review and Meta-AnalysisAhmed Nasr, Arielle Weir, Ashkan Jahangirnia, Dina El Demellawy, Irina Oltean, Joseph de Nanassy, Nayaar Islam, Youssef Nasr대한소아소화기영양학회 · Pediatric Gastroenterology, Hepatology & Nutrition2022 · 제25권 제5호Predictors of Short-Term Outcome of Kasai Portoenterostomy for Biliary Atresia in Infants: a Single-Center StudyGamal El-Tagy, Hanaa El-Karaksy, Noha Adel Yassin, Noha Asem, Omar Nagy Abdelhakeem대한소아소화기영양학회 · Pediatric Gastroenterology, Hepatology & Nutrition2020 · 제23권 제3호Clinical Outcomes of Percutaneous Transhepatic Biliary Drainage in Pediatric Patients following Liver TransplantationAndrea Schneider, Anna M Hunkemöller, Eva-Doreen Pfister, Florian W.R. Vondran, Heiner Wedemeyer, Henrike Lenzen, Jens Dingemann, Klaus Stahl, Nicolas Richter, Tabea von Garrel, Thorben Pape, Ulrich Baumann대한소아소화기영양학회 · Pediatric Gastroenterology, Hepatology & Nutrition2025 · 제28권 제2호Perforated Choledochal Cyst: Its Clinical Implications in Pediatric Patient김해영, 조용훈, Soo-Hong Kim대한소아소화기영양학회 · Pediatric Gastroenterology, Hepatology & Nutrition2020 · 제23권 제3호Outcome of Alagille Syndrome Patients Who Had Previously Received Kasai Operation during Infancy: A Single Center Study이상훈, 이석구, 이화평, 최소윤, 최연호, Ben Kang대한소아소화기영양학회 · Pediatric Gastroenterology, Hepatology & Nutrition2015 · 제18권 제3호

이 간행물의 다른 논문 (8건)